| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022164 |
| Receipt No. | R000025539 |
| Scientific Title | Exploratory clinical trial evaluating the efficacy of covered self-expandable metallic stent with a removal string for benign biliary and pancreatic stricture. |
| Date of disclosure of the study information | 2016/07/15 |
| Last modified on | 2019/05/04 (Ver. 11) |
| Basic information | ||
| Public title | Exploratory clinical trial evaluating the efficacy of covered self-expandable metallic stent with a removal string for benign biliary and pancreatic stricture. | |
| Acronym | Exploratory clinical trial evaluating the efficacy of covered self-expandable metallic stent with a removal string for benign biliary and pancreatic stricture. | |
| Scientific Title | Exploratory clinical trial evaluating the efficacy of covered self-expandable metallic stent with a removal string for benign biliary and pancreatic stricture. | |
| Scientific Title:Acronym | Exploratory clinical trial evaluating the efficacy of covered self-expandable metallic stent with a removal string for benign biliary and pancreatic stricture. | |
| Region |
|
|
| Condition | ||
| Condition | Benign biliary stricture and benign pancreatic stricture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | A standard therapeutic strategy for benign biliary stricture or benign pancreatic stricture is indwelling multiple plastic stents and scheduled stent exchange. A disadvantage of this therapy is that patients have to receive several sessions of ERCP, and there exist some refractory cases who repeat stent exchange for a long time. The objective of present study is to evaluate the rate of stricture resolution and the safety of newly designed covered metallic stent for benign biliary and pancreatic strictures. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Rate of stricture resolution at stent removal after 90 days of indwelling. |
| Key secondary outcomes | 1.Overall rate of stricture resolution at the end of the study period.
2.Rate of stricture recurrence and period until stricture recurrence. 3.Success rate of stent removal. 4.Adverse event at stent removal. 5.Other adverse events. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Insert a covered self-expandable metallic stent with a removal string (Niti-S Kaffes stent, Taewoong medical, Korea) into benign biliary and pancreatic stricture for 90 days. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Benign biliary stricture and benign pancreatic stricture (post-operative biliary stricture, post-liver transplantation bilio-biliary anastomotic stricture, biliary stricture by chronic pancreatitis, pancreatic stricture by chroninc pancreatitis, anastomotic stricture after choledochojejunostomy, and anastomotic stricture after pancreaticojejunostomy).
2. Patients with refractory stricture. (Stricture resolution was not achieved after 6 months of treatment by plastic stent insertion or PTBD insertion). 3. Malignant biliary or pancreatic stricture is ruled out by pathological examination and clinical course. 4. Patients with written informed consent. |
|||
| Key exclusion criteria | 1. Patients with difficulty in endoscopic approach to strictures.
2. Patients withpossibility of malignant biliary or pancreatic stricture. 3. Patients with performance status 3-4. 4. Patients with serious concomitant diseases such as heart failure, respiratory failure, or disturbance of consciousness and who cannot tolerate endoscopic procedures. 5. Patients considered ineligible by the attending physician. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| ynakai-tky@umin.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| tatsusatou-tky@umin.org | |||||||
| Sponsor | |
| Institute | Graduate School of Medicine, The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The University of Tokyo, Clinical research support center |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| Tel | 03-5800-8743 |
| crctky-office@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 30 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025539 |